Mycenax Biotech announced the opening of its "Automated Multi-Formulation" filling line on the 16th. This filling line, which represents an investment of NT$700 million, features world-renowned technology from Germany's Optima, including an automated filling machine, lyophilizer, and isolator. It boasts a flexible design capable of filling various formulations and dosages while allowing for rapid changeovers, thereby increasing production flexibility and enhancing product quality. This development significantly bolsters Mycenax's one-stop CDMO (Contract Development and Manufacturing Organization) services by offering high-quality, sterile filling solutions for a range of biopharmaceuticals.
Read more
